期刊文献+

2010年中国人免疫球蛋白中EV71中和抗体效价的比较研究 被引量:8

Study of anti-EV71 neutralizing titers of human immunoglobulins made in China in 2010
原文传递
导出
摘要 目的:了解2010年我国生产的静注人免疫球蛋白(IVIG)中抗-EV71中和抗体效价的情况,为治疗EV71引起的手足口病(HFMD)提供特异性治疗药物。方法:采用经典微量细胞病变法,应用近2年分离自中国大陆的2株肠道病毒71型(EV71)病毒株,对我国不同血液制品厂家生产的97批IVIG进行抗-EV71中和效价检测,比较不同批次IVIG的EV71中和效价。结果:19家生产企业生产的97批IVIG的EV71中和效价几何平均滴度(GMTs)为1∶180(1∶170~1∶191)。其中有7家生产企业生产的12批制品的中和效价大于1∶256,以S公司生产的20100406批制品效价最高为1∶543,以A公司生产的含有1∶256以上效价的IVIG批数最多(5批),使该公司生产的IVIG的平均EV71中和抗体效价显著高于其他10家企业(P<0.05)。进一步分析显示,该2个公司分别是通过对献血员的EV71中和效价进行筛选,挑选出高效价血浆和选择人群抗体水平较高地区作为血浆来源地进行投料,而制备出了含有高效价EV71中和抗体的IVIG。结论:本研究显示,生产企业只要对原料血浆进行合理控制,制备出含有高效价EV71中和抗体的IVIG是可行的。 Objective:To explore the anti-EV71 titer in human immunoglobulins produced by different blood product manufacturers in China in 2010.To provide specific drugs for hand,foot and mouth disease(HFMD) caused by EV71.Methods:97 Lots of human immunoglobulins for intravenous injection(IVIG) produced by different manufacturers were tested for neutralizing antibodies(NTAb) to EV71 by microneutralization test with 2 different EV71 viruses,which isolated from China's Mainland in the past two years.The difference of anti-EV71 titer in IVIG has been compared.Results:The geometric mean titers(GMTs) of EV71 NTAb in 97 Lots IVIG is 1∶180(1∶170-1∶191).The titers of EV71 NTAb in 12 Lots IVIG produced by 7 different manufacturers have been more than 1∶256,and the IVIG of Lot 20100406 produced by S manufacturer has the highest titer(1∶543).The A manufacturer had made the most Lot of IVIG(5 batches) with anti-EV71 titer higher than 1∶512,that made the average of anti-EV71 from A manufacturer to be obviously higher than other 10 manufacturers(P0.05).Further analysis revealed that S manufacturer had tested the anti-EV71 titers in plasma of raw materials and selected the plasma with high titer of EV71 to produce this Lot IVIG;and A manufacturer selected the areas with high anti-EV71 levels in populations as a plasma source to feed and make IVIGs.Conclusion:This study shows that through controlling the neutralizing antibodies levels to EV71 of raw materials efficiently by the manufacturer,it is scientific and feasible to produce IVIG with high anti-EV71 titer.
出处 《药物分析杂志》 CAS CSCD 北大核心 2011年第10期1918-1923,共6页 Chinese Journal of Pharmaceutical Analysis
关键词 人免疫球蛋白 手足口病(HFMD) 人肠道病毒71型(EV71) 中和抗体 human immunoglobulins hand foot and mouth disease(HFMD) Enterovirus 71(EV71) neutralizing antibodies
  • 相关文献

参考文献6

二级参考文献63

  • 1杨智宏,朱启镕,李秀珠,王晓红,王建设,胡家瑜,唐伟,崔爱利.2002年上海儿童手足口病病例中肠道病毒71型和柯萨奇病毒A组16型的调查[J].中华儿科杂志,2005,43(9):648-652. 被引量:636
  • 2董晓楠,应剑,陈应华.1970~2004年全球肠道病毒71型分离株的分子流行病学分析[J].科学通报,2007,52(9):1021-1027. 被引量:108
  • 3卫生部.手足口病预防控制指南(2008年版)[EB/OL].北京.http://www.gov.crdgzdt/2008-05/03/content_960347.htm,2008.
  • 4Schmidt NJ,Lennette EH,Ho HH.An apparently new enterovirus isolated from patients with disease of the central nervous system.J Infect Dis,1974,129(3):304-309.
  • 5Herrero LJ,Lee CS,Hurrelbrink RJ,et al.Molecular epidemiology of enterovirus 71 in penisular Malaysia,1997 -2000.Arch Virol,2003,148(7):1369-1385.
  • 6Wang JR,Tuan YC,Tsai liP,et al.Change of major genotype of entcrovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000.J Clin Microbiol,2002,40 (1):10-15.
  • 7Scotto-Lavino E,Du G,Frohman MA.3' end eDNA amplification using classic RACE.Nat Pro'toe,2006,1 (6):2742-2745.
  • 8Scotto-Lavino E,Du G,Frohman MA.5' end cDNAamplification using classic RACE.Nat Protoc,2006,1 (6):2555-2562.
  • 9Brown BA,Oberste MS,Alexander JP Jr,et al.Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998.J Virol,1999,73(12):9969-9975.
  • 10Yoke-Fun C,AbuBakar S.Phylogenetie evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes.BMC Microbiol,2006,6:74.

共引文献168

同被引文献85

  • 1陈永宏,徐辉,桂金贵.注射用双黄连治疗小儿手足口病临床观察[J].中国中西医结合急救杂志,2006,13(1):47-47. 被引量:34
  • 2黄文平,唐瑞璠,范真.42例神经源性肺水肿早期机械通气的临床分析[J].中国危重病急救医学,2007,19(2):114-114. 被引量:12
  • 3周世力,艾晓武,董长垣.肠道病毒71型SHZH03结构蛋白基因的遗传进化分析[J].公共卫生与预防医学,2007,18(1):18-20. 被引量:13
  • 4孙琪云,艾辉胜,余长林,乔建辉,郭梅,王丹红,张石.静脉注射免疫球蛋白在急性放射病人救治中的应用[J].解放军医学杂志,2007,32(4):408-408. 被引量:1
  • 5Pellicano R, Caldarola G, Cozzani E. Parodi A: a case of linear immunoglobulin a bullous dermatosis in a patient exposed to sun and an analgesic[ J]. Clin Ther,2009,31 (9) : 1987 - 1990.
  • 6Metz M, Altrichter S, Ardelean E, et al. Anti - immunoglobulin E treatment of patients with recalcitrant physical urticaria [ J ]. Int Arch Allergy Immunol,2011,154(2) :177 - 180.
  • 7Hsieh C L,Grange R,Pu Y,et al. Bioconjugation of barium titanate nanocrystals with immunoglobulin G antibody for second harmonic radiation imaging probes [ J ]. Biomaterials ,2010,31 (8) :2272 - 2277.
  • 8Matsuo T,Ichirramt K,Yashlno T. recurrence as imnamoglobulin CA(IgC,4)- related disease 10 years after radiotherapy to ocular adnexal extranedal marginal zone B - cell lynhoma of mueosa - associated lymphoid tissue[J]. J Clin Exp Hematop,2Ol1,51(2):125 - 133.
  • 9Wang JN ,Yao CT,Yeh CN ,el al. Critical management in Patients with severe enterovirus 71 infection [ J ]. Pediatr Int, 2006,48 ( 3 ) : 250 - 256.
  • 10中华人民共和国卫生部.手足口病诊疗指南(2010年版);肠道病毒71型(EV71)感染重症病例临床救治专家共识(2011年版).http://www.moh.gov.cn.

引证文献8

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部